Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
Authors
Keywords
-
Journal
BMC Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-19
DOI
10.1186/s12916-020-01808-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Temptation of Response-Adaptive Randomization
- (2020) Michael Proschan et al. CLINICAL INFECTIOUS DISEASES
- How to design a dose-finding study using the continual reassessment method
- (2019) Graham M. Wheeler et al. BMC Medical Research Methodology
- The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial
- (2019) Min Dai et al. Trials
- Familywise error control in multi-armed response-adaptive trials
- (2019) D. S. Robertson et al. BIOMETRICS
- TAILoR (TelmisArtan and InsuLin Resistance in HIV): An Adaptive Design Dose-Ranging Phase IIb Randomised Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-Positive Individuals on Combination Antiretroviral Therapy
- (2019) Sudeep Pushpakom et al. CLINICAL INFECTIOUS DISEASES
- Subgroup analysis of treatment effects for misclassified biomarkers with time-to-event data
- (2019) Fang Wan et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- When to keep it simple – adaptive designs are not always useful
- (2019) James M. S. Wason et al. BMC Medicine
- Adaptive platform trials: definition, design, conduct and reporting considerations
- (2019) NATURE REVIEWS DRUG DISCOVERY
- Comparison of methods for control allocation in multiple arm studies using response adaptive randomization
- (2019) Kert Viele et al. Clinical Trials
- Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival
- (2019) Erinn M. Hade et al. Trials
- Designing and evaluating dose-escalation studies made easy: The MoDEsT web app
- (2019) Philip Pallmann et al. Clinical Trials
- EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized clinical trial
- (2019) Noémi Zádori et al. PANCREATOLOGY
- Improving safety of the continual reassessment method via a modified allocation rule
- (2019) Pavel Mozgunov et al. STATISTICS IN MEDICINE
- A web tool for designing and conducting phase I trials using the continual reassessment method
- (2018) Nolan A. Wages et al. BMC CANCER
- Adaptive designs in clinical trials: why use them, and how to run and report them
- (2018) Philip Pallmann et al. BMC Medicine
- An information theoretic phase I-II design for molecularly targeted agents that does not require an assumption of monotonicity
- (2018) Pavel Mozgunov et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activ
- (2018) Patrick Lyden et al. ANNALS OF NEUROLOGY
- An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
- (2018) C R Mehta et al. ANNALS OF ONCOLOGY
- Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
- (2018) Munyaradzi Dimairo et al. BMC Medicine
- The Impact of Early-Phase Trial Design in the Drug Development Process
- (2018) Mark R. Conaway et al. CLINICAL CANCER RESEARCH
- Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints
- (2017) Adam L. Smith et al. JOURNAL OF APPLIED STATISTICS
- Learning health systems, clinical equipoise and the ethics of response adaptive randomisation
- (2017) Alex John London JOURNAL OF MEDICAL ETHICS
- Response-adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
- (2017) Sofía S. Villar et al. PHARMACEUTICAL STATISTICS
- Bayesian adaptive dose-escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy
- (2017) Wai Yin Yeung et al. PHARMACEUTICAL STATISTICS
- Optimized adaptive enrichment designs
- (2017) Thomas Ondra et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment
- (2017) Lisa V Hampson et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
- (2017) Graham M. Wheeler et al. STATISTICS IN MEDICINE
- Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies
- (2016) N. A. Wages et al. ANNALS OF ONCOLOGY
- Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials
- (2016) Y. Yuan et al. CLINICAL CANCER RESEARCH
- Thirty years of phase I radiochemotherapy trials: Latest development
- (2016) Romain Rivoirard et al. EUROPEAN JOURNAL OF CANCER
- Response-adaptive clinical trials: case studies in the medical literature
- (2016) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials
- (2016) Graham M. Wheeler et al. PLoS One
- A multi-stage drop-the-losers design for multi-arm clinical trials
- (2016) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
- (2016) Graham M. Wheeler STATISTICAL PAPERS
- A practical Bayesian design to identify the maximum tolerated dose contour for drug combination trials
- (2016) Liangcai Zhang et al. STATISTICS IN MEDICINE
- Adaptive designs undertaken in clinical research: a review of registered clinical trials
- (2016) Isabella Hatfield et al. Trials
- Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
- (2016) Miranta Antoniou et al. PLoS One
- Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials
- (2015) X. Paoletti et al. ANNALS OF ONCOLOGY
- Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors
- (2015) Makoto Nishio et al. Journal of Thoracic Oncology
- Bayesian adaptive dose-escalation procedures for binary and continuous responses utilizing a gain function
- (2015) Wai Yin Yeung et al. PHARMACEUTICAL STATISTICS
- A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C
- (2015) Nu T. Lu et al. PHYTOTHERAPY RESEARCH
- Unbiased estimation for response adaptive clinical trials
- (2015) Jack Bowden et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- A product of independent beta probabilities dose escalation design for dual-agent phase I trials
- (2015) Adrian P. Mander et al. STATISTICS IN MEDICINE
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- (2015) Peter Bauer et al. STATISTICS IN MEDICINE
- Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Sample Size Re-estimation Designs In Confirmatory Clinical Trials—Current State, Statistical Considerations, and Practical Guidance
- (2015) Yili L. Pritchett et al. Statistics in Biopharmaceutical Research
- Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
- (2015) Sudeep P Pushpakom et al. BMJ Open
- MCPMod: AnRPackage for the Design and Analysis of Dose-Finding Studies
- (2015) Björn Bornkamp et al. Journal of Statistical Software
- bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials
- (2015) Michael Sweeting et al. Journal of Statistical Software
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- (2014) Alexandra C. Graf et al. BIOMETRICAL JOURNAL
- Adaptive designs for clinical trials assessing biomarker-guided treatment strategies
- (2014) J Wason et al. BRITISH JOURNAL OF CANCER
- Dose-finding studies, MCP-Mod, model selection, and model averaging: Two applications in the real world
- (2014) Dominique Verrier et al. Clinical Trials
- Not Too Big, Not Too Small: A Goldilocks Approach To Sample Size Selection
- (2014) Kristine R. Broglio et al. Journal of Biopharmaceutical Statistics
- Improving Probabilities of Correct Interim Decision in Population Enrichment Designs
- (2014) Heiko Götte et al. Journal of Biopharmaceutical Statistics
- Bayesian optimal interval designs for phase I clinical trials
- (2014) Suyu Liu et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- A Bayesian dose-finding design for drug combination clinical trials based on the logistic model
- (2014) Marie-Karelle Riviere et al. PHARMACEUTICAL STATISTICS
- When is a seamless study desirable? Case studies from different pharmaceutical sponsors
- (2014) Robert L. Cuffe et al. PHARMACEUTICAL STATISTICS
- Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials
- (2014) Mourad Tighiouart et al. PLoS One
- Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control
- (2014) Mourad Tighiouart et al. STATISTICS IN MEDICINE
- Competing designs for drug combination in phase I dose-finding clinical trials
- (2014) M.-K. Riviere et al. STATISTICS IN MEDICINE
- A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
- (2014) James M. S. Wason et al. STATISTICS IN MEDICINE
- Can Response-Adaptive Randomization Increase Participation in Acute Stroke Trials?
- (2014) Jason S. Tehranisa et al. STROKE
- Principles of dose finding studies in cancer: a comparison of trial designs
- (2013) Thomas Jaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
- (2013) Thomas Jaki Clinical Trials
- Optimal sequential designs in phase I studies
- (2013) David Azriel COMPUTATIONAL STATISTICS & DATA ANALYSIS
- Adaptive designs for dual-agent phase I dose-escalation studies
- (2013) Jennifer A. Harrington et al. Nature Reviews Clinical Oncology
- Escalation with overdose control for phase I drug-combination trials
- (2013) Yun Shi et al. STATISTICS IN MEDICINE
- Group sequential enrichment design incorporating subgroup selection
- (2013) Baldur P. Magnusson et al. STATISTICS IN MEDICINE
- Model-based dose finding under model uncertainty using general parametric models
- (2013) José Pinheiro et al. STATISTICS IN MEDICINE
- A Practical Guide to Data Monitoring Committees in Adaptive Trials
- (2013) Matilde Sanchez-Kam et al. Therapeutic Innovation & Regulatory Science
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- (2012) D. Magirr et al. BIOMETRIKA
- Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method
- (2012) Emily M Van Meter et al. Clinical Trials
- Adaptive Clinical Trials
- (2012) William J. Meurer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
- (2012) Shein-Chung Chow et al. Journal of Biopharmaceutical Statistics
- Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
- (2012) Christophe Le Tourneau et al. PLoS One
- The construction of optimal designs for dose-escalation studies
- (2012) Linda M. Haines et al. STATISTICS AND COMPUTING
- A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy
- (2012) Wei Zhong et al. STATISTICS IN MEDICINE
- Paradigms for adaptive statistical information designs: practical experiences and strategies
- (2012) Sue-Jane Wang et al. STATISTICS IN MEDICINE
- Incorporating lower grade toxicity information into dose finding designs
- (2011) Alexia Iasonos et al. Clinical Trials
- Dose-finding design for multi-drug combinations
- (2011) Nolan A Wages et al. Clinical Trials
- Familywise Error Control in Multi-Armed Response-Adaptive Two-Stage Designs
- (2011) Georg Gutjahr et al. Journal of Biopharmaceutical Statistics
- Using randomization tests to preserve type I error with response adaptive and covariate adaptive randomization
- (2011) Richard Simon et al. STATISTICS & PROBABILITY LETTERS
- Bayesian adaptive clinical trials: a dream for statisticians only?
- (2011) Sylvie Chevret STATISTICS IN MEDICINE
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Continual reassessment method with multiple toxicity constraints
- (2010) S. M. Lee et al. BIOSTATISTICS
- An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials
- (2010) Arzu Onar-Thomas et al. Contemporary Clinical Trials
- Adaptive Clinical Trials: The Promise and the Caution
- (2010) Donald A. Berry JOURNAL OF CLINICAL ONCOLOGY
- Outcome-Adaptive Randomization: Is It Useful?
- (2010) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Group sequential trials revisited: Simple implementation using SAS
- (2010) John Whitehead STATISTICAL METHODS IN MEDICAL RESEARCH
- Dose Finding with Escalation with Overdose Control (EWOC) in Cancer Clinical Trials
- (2010) Mourad Tighiouart et al. STATISTICAL SCIENCE
- Adaptive increase in sample size when interim results are promising: A practical guide with examples
- (2010) Cyrus R. Mehta et al. STATISTICS IN MEDICINE
- Sample size re-estimation in clinical trials
- (2009) Michael A. Proschan BIOMETRICAL JOURNAL
- Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium
- (2009) Arzu Onar et al. Journal of Biopharmaceutical Statistics
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
- (2009) Werner Brannath et al. STATISTICS IN MEDICINE
- A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies
- (2008) Alexia Iasonos et al. Clinical Trials
- Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
- (2008) Xian Zhou et al. Clinical Trials
- Speeding up the Evaluation of New Agents in Cancer
- (2008) M. K. B. Parmar et al. JNCI-Journal of the National Cancer Institute
- Sequential continual reassessment method for two-dimensional dose finding
- (2008) Ying Yuan et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search